1 active not recruiting, 1 completed, 1 suspended. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Active not recruiting 1, Completed 1, Suspended 1 |
| Phase 1 | 1 | Suspended 1 |
Follow Diffuse Large B-Cell Lymphoma Unclassifiable: new trials by email Literature Review of Diffuse Large B-Cell Lymphoma Unclassifiable trials Research Report on Diffuse Large B-Cell Lymphoma Unclassifiable
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Carboplatin, Etoposide, Ifosfamide - Diffuse Large B-Cell Lymphoma Unclassifiable, Recurrent Diffuse Large B-Cell Lymphoma | Phase 2 | Active not recruiting | City of Hope Medical Center | 41 | 2021-01-18 | 2026-09-11 |
| Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma Cyclophosphamide, Doxorubicin Hydrochloride, Nivolumab - Aggressive Non-Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | Suspended | Northwestern University | 30 | 2018-11-20 | 2022-08-15 |
| Smart Start: A Phase II Study of Rituximab, Lenalidomide, and Ibrutinib Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide - Diffuse Large B-Cell Lymphoma Unclassifiable | Phase 2 | Completed | M.D. Anderson Cancer Center | 60 | 2016-03-29 | 2024-03-13 |
Lymphoma, B-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Lymphoma, B-Cell (1)
CT-P10 (3) · Rituximab (3) · Cyclophosphamide (2) · Doxorubicin (2) · Etoposide (2) · Prednisone (2) · Vincristine (2) · deltacortene (2) · prednylidene (2) · Carboplatin (1) · Ifosfamide (1) · Lenalidomide (1) · Nivolumab (1) · ibrutinib (1) · polatuzumab vedotin (1)
City of Hope Medical Center (1) · M.D. Anderson Cancer Center (1) · Northwestern University (1)
United States (3)
Alex F Herrera (1) · Jason Westin (1) · Reem Karmali, MD (1)
PMID 35952327, PMID 39319495, PMID 40706069, PMID 41845899
P30CA033572 (1), P30CA060553 (1)